drugset / Trial / NCT00373542

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

NCT00373542

Phase 4 Completed 39 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of ropinirole CR-RLS in the treatment of patients with Restless Legs Syndrome and associated sleep disturbance and period limb movements during sleep.

Timeline

Start
2006-10
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule